{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:40:39Z","timestamp":1791434439993,"version":"4.3.3"},"reference-count":125,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbagen.2026.130982","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:54:03Z","timestamp":1784908443000},"page":"130982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Innovative approaches in the therapeutic application of EpCAM aptamer for targeted cancer treatment: A review"],"prefix":"10.1016","volume":"1870","author":[{"given":"Mohammad Hossein","family":"Hosseinzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monireh","family":"Askarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Ebrahimnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Rafiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezvan","family":"Yazdian-Robati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2026.130982_bb0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semcancer.2019.11.002","article-title":"Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy","volume":"69","author":"Raj","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0010","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ijbiomac.2019.11.118","article-title":"Therapeutic applications of AS1411 aptamer, an update review","volume":"155","author":"Yazdian-Robati","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0015","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biochi.2018.09.001","article-title":"SELEX methods on the road to protein targeting with nucleic acid aptamers","volume":"154","author":"Bayat","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.bbagen.2026.130982_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156124","article-title":"AS1411 aptamer in melanoma therapy: harnessing targeted strategies for precision treatment","volume":"273","author":"Askarzadeh","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbagen.2026.130982_bb0025","doi-asserted-by":"crossref","first-page":"7766","DOI":"10.1039\/C6TB02564A","article-title":"Aptamer application in targeted delivery systems for diagnosis and treatment of breast cancer","volume":"4","author":"Shahdordizadeh","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bbagen.2026.130982_bb0030","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/acs.molpharmaceut.8b00124","article-title":"A novel AS1411 aptamer-based three-way junction pocket DNA nanostructure loaded with doxorubicin for targeting cancer cells in vitro and in vivo","volume":"15","author":"Taghdisi","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbagen.2026.130982_bb0035","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1021\/ac400366b","article-title":"Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture","volume":"85","author":"Song","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbagen.2026.130982_bb0040","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/1061186X.2022.2148679","article-title":"EpCAM aptamer activated 5-FU-loaded PLGA nanoparticles in CRC treatment; in vitro and in vivo study","volume":"31","author":"Yavari","year":"2023","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bbagen.2026.130982_bb0045","article-title":"Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2026.130982_bb0050","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10555-020-09898-3","article-title":"Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?","volume":"39","author":"Gires","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbagen.2026.130982_bb0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ctrv.2011.04.002","article-title":"Epithelial cell adhesion molecule expression (CD326) in cancer: a short review","volume":"38","author":"Patriarca","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbagen.2026.130982_bb0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.bjc.6603494","article-title":"EpCAM (CD326) finding its role in cancer","volume":"96","author":"Baeuerle","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbagen.2026.130982_bb0065","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3390\/cells9061361","article-title":"Current view on EpCAM structural biology","volume":"9","author":"Gaber","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbagen.2026.130982_bb0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.critrevonc.2018.03.006","article-title":"EpCAM duality becomes this molecule in a new Dr. Jekyll and Mr. Hyde tale","volume":"126","author":"Herreros-Pomares","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113891","article-title":"Nanotechnology-based delivery of CRISPR\/Cas9 for cancer treatment","volume":"176","author":"Xu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbagen.2026.130982_bb0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/jcp.2011.090274","article-title":"EpCAM expression in primary tumour tissues and metastases: An immunohistochemical analysis","volume":"64","author":"Spizzo","year":"2011","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ebiom.2017.05.025","article-title":"Is ep-CAM expression a diagnostic and prognostic biomarker for colorectal cancer? A systematic meta-analysis","volume":"20","author":"Han","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbagen.2026.130982_bb0090","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/gcc.21926","article-title":"Analysis of exosome release and its prognostic value in human colorectal cancer","volume":"51","author":"Silva","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bbagen.2026.130982_bb0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40164-022-00352-4","article-title":"Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside","volume":"11","author":"Liu","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1242231","article-title":"Clinicopathological and prognostic value of epithelial cell adhesion molecule in solid tumours: a meta-analysis","volume":"13","author":"Ding","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0105","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2174\/1568009618666180102102311","article-title":"Antibody based EpCAM targeted therapy of cancer, review and update","volume":"18","author":"Eyvazi","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbagen.2026.130982_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188436","article-title":"EpCAM cellular functions in adhesion and migration, and potential impact on invasion: a critical review","volume":"1874","author":"Fagotto","year":"2020","journal-title":"Biochim. Biophys. Acta - Rev. Cancer"},{"key":"10.1016\/j.bbagen.2026.130982_bb0115","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1158\/0008-5472.CAN-07-0908","article-title":"Activation of hepatic stem cell marker EpCAM by Wnt\u2013\u03b2-catenin signaling in hepatocellular carcinoma","volume":"67","author":"Yamashita","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2026.130982_bb0120","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.7150\/ijms.96274","article-title":"Cross-talk between the TGF-\u03b2 and cell adhesion signaling pathways in cancer","volume":"21","author":"Liao","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbagen.2026.130982_bb0125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.14715\/cmb\/2022.68.5.26","article-title":"The regulatory mechanism of EpCAM N-glycosylation-mediated MAPK and PI3K\/Akt pathways on epithelial-mesenchymal transition in breast cancer cells","volume":"68","author":"Wen","year":"2022","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0130","doi-asserted-by":"crossref","first-page":"G233","DOI":"10.1152\/ajpgi.00069.2014","article-title":"EpCAM and the biology of hepatic stem\/progenitor cells","volume":"308","author":"Doll\u00e9","year":"2015","journal-title":"Am. J. Physiol. - Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0135","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.bbamem.2013.04.018","article-title":"EpCAM: structure and function in health and disease","volume":"1828","author":"Schnell","year":"2013","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.bbagen.2026.130982_bb0140","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1021\/acs.analchem.4c05695","article-title":"In situ and in vivo evaluation of multiplex protein-specific glycosylation of tumors with a dual-SERS encoding strategy","volume":"97","author":"Wu","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbagen.2026.130982_bb0145","doi-asserted-by":"crossref","first-page":"10345","DOI":"10.1021\/acs.nanolett.5c01468","article-title":"Overcoming epithelial\u2013mesenchymal transition challenges in cancer detection through a dual-targeting strategy","volume":"25","author":"Tong","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.bbagen.2026.130982_bb0150","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1021\/acsabm.5c01173","article-title":"Dual aptamers functionalized biomimetic magnetic nanomaterials for high-efficient capture of circulating tumor cells","volume":"8","author":"Xu","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bbagen.2026.130982_bb0155","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1349-7006.2011.01897.x","article-title":"RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule","volume":"102","author":"Shigdar","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbagen.2026.130982_bb0160","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.2147\/DDDT.S322854","article-title":"Selection of DNA aptamers recognizing EpCAM-positive prostate cancer by cell-SELEX for in vitro and in vivo MR imaging","volume":"15","author":"Zhong","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.bbagen.2026.130982_bb0165","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/mt.2015.108","article-title":"Aptamers selected to postoperative lung adenocarcinoma detect circulating tumor cells in human blood","volume":"23","author":"Zamay","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbagen.2026.130982_bb0170","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/cancers11030351","article-title":"Development of DNA aptamers to native EpCAM for isolation of lung circulating tumor cells from human blood","volume":"11","author":"Zamay","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbagen.2026.130982_bb0175","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.7150\/thno.20168","article-title":"Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery","volume":"7","author":"Xiang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.bbagen.2026.130982_bb0180","first-page":"2783","article-title":"Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer","volume":"18","author":"Subramanian","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.bbagen.2026.130982_bb0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/nat.2019.0807","article-title":"Bifunctional aptamer\u2013doxorubicin conjugate crosses the blood\u2013brain barrier and selectively delivers its payload to EpCAM-positive tumor cells","volume":"30","author":"MacDonald","year":"2020","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.bbagen.2026.130982_bb0190","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1039\/D4BM01471E","article-title":"A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cells","volume":"13","author":"Liu","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bbagen.2026.130982_bb0195","first-page":"3615","article-title":"Neocarzinostatin, aptamer conjugates for targeting EpCAM-positive tumor cells","volume":"37","author":"Athyala","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bbagen.2026.130982_bb0200","series-title":"Recent Advances in Nanocarriers for Pancreatic Cancer Therapy","first-page":"375","article-title":"Chapter 15 - aptamer-mediated nano-therapy for pancreatic cancer","author":"Rahimnia","year":"2024"},{"key":"10.1016\/j.bbagen.2026.130982_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189558","article-title":"Selection and targeting of EpCAM protein by ssDNA aptamer","volume":"12","author":"Alshaer","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.bbagen.2026.130982_bb0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12929-014-0108-9","article-title":"EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex","volume":"22","author":"Subramanian","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbagen.2026.130982_bb0215","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/bios13121027","article-title":"A novel aptamer biosensor based on a localized surface plasmon resonance sensing chip for high-sensitivity and rapid enrofloxacin detection","volume":"13","author":"Wang","year":"2023","journal-title":"Biosensors"},{"key":"10.1016\/j.bbagen.2026.130982_bb0220","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.7150\/thno.85419","article-title":"Aptamer-engineered (nano)materials for theranostic applications","volume":"13","author":"Rabiee","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.bbagen.2026.130982_bb0225","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/pharmaceutics15020656","article-title":"Current advances in lipid nanosystems intended for topical and transdermal drug delivery applications","volume":"15","author":"Akombaetwa","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbagen.2026.130982_bb0230","article-title":"From lab to industrial development of lipid nanocarriers using quality by design approach","volume":"8","author":"Buya","year":"2024","journal-title":"Int. J. Pharm.: X"},{"key":"10.1016\/j.bbagen.2026.130982_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106333","article-title":"Solid lipid nanoparticles (SLNs), the potential novel vehicle for enhanced in vivo efficacy of hesperidin as an anti-inflammatory agent","volume":"131","author":"Shahraki","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbagen.2026.130982_bb0240","first-page":"87","article-title":"Nanostructured lipid carriers (NLCs) composed of argan oil, the potential novel vehicle for caffeine delivery to stratum corneum and hair follicles","volume":"9","author":"Shiehzadeh","year":"2022","journal-title":"Nanomed. J."},{"key":"10.1016\/j.bbagen.2026.130982_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120571","article-title":"Design of liposomes as drug delivery system for therapeutic applications","volume":"601","author":"Guimar\u00e3es","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbagen.2026.130982_bb0250","first-page":"401","article-title":"Functionalized liposomes for targeted breast cancer drug delivery","volume":"24","author":"Nel","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bbagen.2026.130982_bb0255","series-title":"Recent Advances in Nanocarriers for Pancreatic Cancer Therapy","first-page":"95","article-title":"Chapter 5 - liposome- and niosome-based drug delivery for pancreatic cancer","author":"Yazdian-Robati","year":"2024"},{"key":"10.1016\/j.bbagen.2026.130982_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.bbagen.2026.130982_bb0265","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ebiom.2019.03.018","article-title":"Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release","volume":"42","author":"Lian","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbagen.2026.130982_bb0270","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s11671-020-03334-9","article-title":"Anti-Epcam aptamer (Syl3c)-functionalized liposome for targeted delivery of doxorubicin: in vitro and in vivo antitumor studies in mice bearing C26 colon carcinoma","volume":"15","author":"Mashreghi","year":"2020","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.bbagen.2026.130982_bb0275","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1021\/acs.molpharmaceut.9b00867","article-title":"EpCAM aptamer-functionalized cationic liposome-based nanoparticles loaded with miR-139-5p for targeted therapy in colorectal cancer","volume":"16","author":"Zhao","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbagen.2026.130982_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108485","article-title":"Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs","volume":"691","author":"Hashemi","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2026.130982_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38165","article-title":"The drug release of PLGA-based nanoparticles and their application in treatment of gastrointestinal cancers","volume":"10","author":"Sun","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bbagen.2026.130982_bb0290","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1039\/D0TB02988B","article-title":"A PLGA nanofiber microfluidic device for highly efficient isolation and release of different phenotypic circulating tumor cells based on dual aptamers","volume":"9","author":"Wu","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bbagen.2026.130982_bb0295","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2014.12.035","article-title":"Epithelial cell adhesion molecule aptamer conjugated PEG\u2013PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro","volume":"479","author":"Alibolandi","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbagen.2026.130982_bb0300","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/jbm.a.36986","article-title":"Synthesis of combinatorial Janus nanoparticles based on EpCAM-PEG\/PCL for targeted therapy of human colorectal adenocarcinoma","volume":"108","author":"Khezrian","year":"2020","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.bbagen.2026.130982_bb0305","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nano.2014.09.002","article-title":"Multifunctional nanoparticle\u2013EpCAM aptamer bioconjugates: a paradigm for targeted drug delivery and imaging in cancer therapy","volume":"11","author":"Das","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bbagen.2026.130982_bb0310","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1556-276X-9-247","article-title":"Dendrimers: synthesis, applications, and properties","volume":"9","author":"Abbasi","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.bbagen.2026.130982_bb0315","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mtchem.2019.04.004","article-title":"Poly(amidoamine) dendrimers: covalent and supramolecular synthesis","volume":"13","author":"Lyu","year":"2019","journal-title":"Mater. Today Chem."},{"key":"10.1016\/j.bbagen.2026.130982_bb0320","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejpb.2016.03.013","article-title":"Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo","volume":"102","author":"Taghdisi","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bbagen.2026.130982_bb0325","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.xphs.2022.07.009","article-title":"PAMAM dendrimers: a review of methodologies employed in biopharmaceutical classification","volume":"111","author":"Guizze","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2026.130982_bb0330","article-title":"Aptamer-grafted, cell membrane-coated dendrimer loaded with doxorubicin as a targeted nanosystem against epithelial cellular adhesion molecule (EpCAM) for triple negative breast cancer therapy","volume":"86","author":"Sheikh","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0335","doi-asserted-by":"crossref","first-page":"10305","DOI":"10.2147\/IJN.S282107","article-title":"Aptamer-functionalized dendrimer delivery of plasmid-encoding lncRNA MEG3 enhances gene therapy in castration-resistant prostate cancer","volume":"15","author":"Tai","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbagen.2026.130982_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.598722","article-title":"A review of mesoporous silica nanoparticle delivery systems in chemo-based combination cancer therapies","volume":"8","author":"Gao","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.bbagen.2026.130982_bb0345","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejps.2015.12.014","article-title":"EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery","volume":"83","author":"Xie","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2026.130982_bb0350","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.2147\/IJN.S143293","article-title":"EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer","volume":"12","author":"Li","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbagen.2026.130982_bb0355","doi-asserted-by":"crossref","first-page":"57362","DOI":"10.1021\/acsami.0c17660","article-title":"Co-delivery of sorafenib and CRISPR\/Cas9 based on targeted core\u2013shell hollow mesoporous organosilica nanoparticles for synergistic HCC therapy","volume":"12","author":"Zhang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bbagen.2026.130982_bb0360","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2217\/nnm-2017-0028","article-title":"Synthesis of theranostic epithelial cell adhesion molecule targeted mesoporous silica nanoparticle with gold gatekeeper for hepatocellular carcinoma","volume":"12","author":"Babaei","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bbagen.2026.130982_bb0365","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s12257-019-0512-9","article-title":"Albumin: An emerging opportunity in drug delivery, Biotechnol","volume":"25","author":"Rahimizadeh","year":"2020","journal-title":"Bioprocess Eng."},{"key":"10.1016\/j.bbagen.2026.130982_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2022.128429","article-title":"Concentration-dependent assembly of bovine serum albumin molecules in the doxorubicin loading process: molecular dynamics simulation","volume":"640","author":"Mollazadeh","year":"2022","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.bbagen.2026.130982_bb0375","doi-asserted-by":"crossref","first-page":"46366","DOI":"10.1039\/C6RA08481H","article-title":"Targeted delivery of vincristine to T-cell acute lymphoblastic leukemia cells using an aptamer-modified albumin conjugate","volume":"6","author":"Taghdisi","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbagen.2026.130982_bb0380","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.2147\/IJN.S267177","article-title":"Targeted treatment of colon cancer with aptamer-guided albumin nanoparticles loaded with docetaxel","volume":"15","author":"Yu","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbagen.2026.130982_bb0385","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jconrel.2025.01.035","article-title":"Albumin-based delivery systems: recent advances, challenges, and opportunities","volume":"380","author":"Murphy","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbagen.2026.130982_bb0390","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.2147\/IJN.S467876","article-title":"Albumin nanoparticle-based drug delivery systems","volume":"19","author":"Qu","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbagen.2026.130982_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114575","article-title":"Bovine serum albumin-gold nanoclusters protein corona stabilized polystyrene nanoparticles as dual-color fluorescent nanoprobes for breast cancer detection","volume":"215","author":"Wu","year":"2022","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.bbagen.2026.130982_bb0400","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2217\/nnm-2016-0316","article-title":"Magnetic nanoparticles for precision oncology: Theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy","volume":"12","author":"Zhu","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bbagen.2026.130982_bb0405","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.3390\/nano12193323","article-title":"Biocompatible iron oxide nanoparticles for targeted cancer gene therapy: a review","volume":"12","author":"Zhang","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.bbagen.2026.130982_bb0410","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijpharm.2015.02.031","article-title":"Single-walled carbon nanotubes functionalized with aptamer and piperazine\u2013polyethylenimine derivative for targeted siRNA delivery into breast cancer cells","volume":"485","author":"Mohammadi","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbagen.2026.130982_bb0415","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202000647","article-title":"Bioinspired DNA nanointerface with anisotropic aptamers for accurate capture of circulating tumor cells","volume":"7","author":"Qin","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbagen.2026.130982_bb0420","doi-asserted-by":"crossref","first-page":"9935","DOI":"10.1021\/acs.nanolett.2c03377","article-title":"Programming DNA aptamer arrays of prescribed spatial features with enhanced bioavailability and cell growth modulation","volume":"22","author":"Xu","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.bbagen.2026.130982_bb0425","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1039\/C7DT04232A","article-title":"Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application","volume":"47","author":"Pasha","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bbagen.2026.130982_bb0430","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12951-021-01056-3","article-title":"Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy","volume":"19","author":"Iranpour","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.jelechem.2019.113655","article-title":"Sensitive electrochemical aptasensor for detecting EpCAM with silica nanoparticles and quantum dots for signal amplification","volume":"856","author":"Zhu","year":"2020","journal-title":"J. Electroanal. Chem."},{"key":"10.1016\/j.bbagen.2026.130982_bb0440","article-title":"Using magnetic mesoporous silica nanoparticles armed with EpCAM aptamer as an efficient platform for specific delivery of 5-fluorouracil to colorectal cancer cells","volume":"10","author":"Al-Mosawi","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0445","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.snb.2017.02.012","article-title":"Development of targeted multimodal imaging agent in ionizing radiation-free approach for visualizing hepatocellular carcinoma cells","volume":"245","author":"Pilapong","year":"2017","journal-title":"Sens. Actuators B: Chem."},{"key":"10.1016\/j.bbagen.2026.130982_bb0450","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s11033-021-06199-y","article-title":"Fabrication and evaluation of aptamer-conjugated paclitaxel-loaded magnetic nanoparticles for targeted therapy on breast cancer cells","volume":"48","author":"Khodadadi","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbagen.2026.130982_bb0455","doi-asserted-by":"crossref","first-page":"30687","DOI":"10.1039\/C5RA01566A","article-title":"Magnetic-EpCAM nanoprobe as a new platform for efficient targeting, isolating and imaging hepatocellular carcinoma","volume":"5","author":"Pilapong","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbagen.2026.130982_bb0460","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijpharm.2014.07.036","article-title":"Smart magnetic nanoparticle-aptamer probe for targeted imaging and treatment of hepatocellular carcinoma","volume":"473","author":"Pilapong","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbagen.2026.130982_bb0465","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1818316","article-title":"Aptamers and aptamer-drug conjugates as synthetic immune modulators for cancer immunotherapy","volume":"17","author":"Arshad","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2026.102751","article-title":"Small but mighty: peptides as next-generation immunotargeting agents in gynecological cancers","volume":"67","author":"Garg","year":"2026","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0475","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1083738","article-title":"Aptamers: a feasible technology in cancer immunotherapy","volume":"2016","author":"Soldevilla","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bbagen.2026.130982_bb0480","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.ymthe.2024.06.006","article-title":"Targeting PD-L1 in cholangiocarcinoma using nanovesicle-based immunotherapy","volume":"32","author":"Gondaliya","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbagen.2026.130982_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.172160","article-title":"An engineered nanosystem for reprogramming circulating malignant cells and the tumor-immune axis","volume":"528","author":"Yan","year":"2026","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bbagen.2026.130982_bb0490","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12929-024-01069-8","article-title":"EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment","volume":"31","author":"Dutta","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbagen.2026.130982_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.123120","article-title":"A smart responsive NIR-operated chitosan-based nanoswitch to induce cascade immunogenic tumor ferroptosis via cytokine storm","volume":"351","author":"Xu","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bbagen.2026.130982_bb0500","doi-asserted-by":"crossref","first-page":"31183","DOI":"10.1021\/acsnano.5c10067","article-title":"A spatiotemporally controllable DNA hydrogel mesh for focused antimetastasis therapy of cancer","volume":"19","author":"Yang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbagen.2026.130982_bb0505","doi-asserted-by":"crossref","first-page":"30033","DOI":"10.1021\/jacs.4c06338","article-title":"Polyvalent aptamer nanodrug conjugates enable efficient tumor cuproptosis therapy through copper overload and glutathione depletion","volume":"146","author":"Wang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2026.130982_bb0510","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jcis.2024.01.066","article-title":"Multifunctional metal-coordinated co-assembled carrier-free nanoplatform based on dual-drugs for ferroptosis-mediated cocktail therapy of hepatocellular carcinoma growth and metastasis","volume":"660","author":"Zhao","year":"2024","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bbagen.2026.130982_bb0515","series-title":"Recent Advances in Nanocarriers for Pancreatic Cancer Therapy","first-page":"401","article-title":"Chapter 16 - photodynamic therapy for pancreatic cancer","author":"Yazdian-Robati","year":"2024"},{"key":"10.1016\/j.bbagen.2026.130982_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pmatsci.2018.07.005","article-title":"Nanomaterials as photothermal therapeutic agents","volume":"99","author":"Chen","year":"2019","journal-title":"Prog. Mater. Sci."},{"key":"10.1016\/j.bbagen.2026.130982_bb0525","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202501209","article-title":"An aptamer-conjugated AIEgen for targeted bioimaging and photodynamic therapy of cancer cells","volume":"31","author":"Chen","year":"2025","journal-title":"Chem. A Eur. J."},{"key":"10.1016\/j.bbagen.2026.130982_bb0530","article-title":"EpCAM aptamer integrated graphene nanosystem for combined anti-ovarian cancer therapy","volume":"95","author":"Maheshwari","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2024.135176","article-title":"EpCAM aptamer-engineered, azadiradione-loaded, chemo-photo-responsive nano-erythroliposomes for the treatment of triple-negative breast cancer","volume":"703","author":"Sharma","year":"2024","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.bbagen.2026.130982_bb0540","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1039\/D2BM00803C","article-title":"A multifunctional theranostics nanosystem featuring self-assembly of alcohol-abuse drug and photosensitizers for synergistic cancer therapy","volume":"10","author":"Wu","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bbagen.2026.130982_bb0545","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301413","article-title":"Mn2+\/Ir3+\u2212doped and CaCO3-covered Prussian blue nanoparticles with indocyanine green encapsulation for tumor microenvironment modulation and image-guided synergistic cancer therapy","volume":"12","author":"Ma","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bbagen.2026.130982_bb0550","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2217\/nnm-2021-0257","article-title":"AS1411 and EpDT3-conjugated silver nanotriangle-mediated photothermal therapy for breast cancer and cancer stem cells","volume":"16","author":"Yang","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bbagen.2026.130982_bb0555","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.7150\/thno.11692","article-title":"EpCAM aptamer-mediated survivin silencing sensitized cancer stem cells to doxorubicin in a breast cancer model","volume":"5","author":"Wang","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.bbagen.2026.130982_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132407","article-title":"EpCAM aptamer-siRNA chimera targets and regress epithelial cancer","volume":"10","author":"Subramanian","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.bbagen.2026.130982_bb0565","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1158\/1535-7163.MCT-15-0201-T","article-title":"Gene knockdown by EpCAM aptamer\u2013siRNA chimeras suppresses epithelial breast cancers and their tumor-initiating cells","volume":"14","author":"Gilboa-Geffen","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbagen.2026.130982_bb0570","first-page":"1170","article-title":"Aptamer functionalised small gold nanorod-based nanoprobes: targeting EpCAM over-expressed cancer cells for photothermal therapy","volume":"11","author":"Mbalaha","year":"2024","journal-title":"Austin J. Anal. Pharm. Chem."},{"key":"10.1016\/j.bbagen.2026.130982_bb0575","doi-asserted-by":"crossref","first-page":"8486","DOI":"10.1073\/pnas.1913242117","article-title":"In silico design and validation of high-affinity RNA aptamers targeting epithelial cellular adhesion molecule dimers","volume":"117","author":"Bell","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2026.130982_bb0580","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1021\/ac501423g","article-title":"Monoclonal surface display SELEX for simple, rapid, efficient, and cost-effective aptamer enrichment and identification","volume":"86","author":"Zhu","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbagen.2026.130982_bb0585","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202155","article-title":"Multi-targeting nano-systems targeting heterogeneous cancer cells for therapeutics and biomarker detection","volume":"12","author":"Ren","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bbagen.2026.130982_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114542","article-title":"Aptamer-functionalized nanoparticles for CRISPR-Cas9 delivery to circulating malignant cells for therapeutic efficacy evaluation","volume":"390","author":"Liao","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbagen.2026.130982_bb0595","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00604-024-06504-z","article-title":"Fluorescent identification of immunomagnetically captured CTCs using triplex-aptamer-targeted dendritic SiO2@Fe3O4 nanocomposite","volume":"191","author":"Wang","year":"2024","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.bbagen.2026.130982_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2026.116902","article-title":"Dual-aptamer indirect magnetic capture method for enhanced detection of circulating tumor cells in non-small cell lung cancer","volume":"221","author":"Pu","year":"2026","journal-title":"Microchem. J."},{"key":"10.1016\/j.bbagen.2026.130982_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1443843","article-title":"Capturing and releasing of hepatocellular carcinoma EpCAM+ and EpCAM- circulating tumor cells based on photosensitive intelligent nanoreactor","volume":"12","author":"Mao","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bbagen.2026.130982_bb0610","article-title":"Heteromultivalency enhances resolution in cellular mechanical sorting","volume":"137","author":"Zhang","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2026.130982_bb0615","doi-asserted-by":"crossref","first-page":"12822","DOI":"10.1021\/acsami.2c22820","article-title":"Engineering circular aptamer assemblies with tunable selectivity to cell membrane antigens in vitro and in vivo","volume":"15","author":"Qi","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bbagen.2026.130982_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2026.129606","article-title":"Aptamer-integrated DNA tetrahedral sensors for cancer cell imaging and invasiveness assessment","volume":"305","author":"Zou","year":"2026","journal-title":"Talanta"},{"key":"10.1016\/j.bbagen.2026.130982_bb0625","article-title":"DNA framework-ensembled aptamers enhance fluid stability in circulating tumor cells capture for tumor treatment evaluation","volume":"137","author":"Chen","year":"2025","journal-title":"Angew. Chem. Int. Ed."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:13Z","timestamp":1786119193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416526000826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":125,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0304416526000826"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130982","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovative approaches in the therapeutic application of EpCAM aptamer for targeted cancer treatment: A review","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130982"}}